Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 390 participants.

Also called NCT06115070

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 390 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06115070
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06115070. Randomized; single masking; primary purpose treatment. Start 2025-03-01 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
Acronym
ALLOW
Condition
Thrombosis
Condition
Acute Ischemic Stroke (AIS)
Intervention (Drug)
Intravenous thrombolysis (alteplase and other guideline-recommended thrombolytic agents)
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)

Record details

Record id
cardio:ct-nct06115070
Content hash
745e807fc77be433cc071ad46d58098be8c3be91963ab085f92cd2d22ab2ae0a